Goodwin is adept in patent prosecution across life sciences, biotech, pharmaceuticals, medical devices, software, hardware, data analytics, consumer electronics, business methods, financial systems, and e-commerce. Boston-based co-head Catherine McCarty specializes in pharmaceutical and chemistry-related IP, including small molecules, salts, solid forms, and chemical processes, and has handled related litigation. Silicon Valley-based co-chair James Riley advises emerging tech companies and venture capital firms on IP strategy, licensing, AI, data privacy, and technology-related financings and M&A. In Boston, Theresa Kavanaugh develops patent strategies for therapeutics, including NCEs, and biologics, guiding clients on FDA approvals, M&A, partnerships, and financings. Also in Boston are Scott Bluni and Duncan Greenhalgh. Other key contacts include Michael Shuster in San Francisco.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'Michael Shuster brings decades of experience in IP litigation and protection - from the moment I started talking about what we were developing to where we want to take the technology, I felt that Michael was a partner working alongside me vs an external lawyer just putting in the time. That partnership is not only more pleasant to work with, but has fomented a great collaboration and partnership in driving my company's portfolio and product forward.'
Key clients
- Insulet Corporation
- Blueprint Medicines
- Vigil Neuroscience
- Kymera Therapeutics
- Sionna Therapeutics
- Anthos Therapeutics
- Calico Labs
- Immuno-Therapeutics Companies
- Ansa Biotechnologies
- Mission Bio, Inc.
- Ouro Medicines
- TRex Bio
Work highlights
Advised on the patent aspects of Blueprint Medicines Corporation’s (Nasdaq: BPMC) $9.5 billion acquisition by Sanofi (NASDAQ: SNY)
Advised Insulet Corporation in the case Insulet Corporation v. EOFlow Co. Ltd, achieving a landmark victory.
Advised on the patent aspects of Anthos Therapeutics’ acquisition by Novartis for up to $3.1 billion.
Practice head
Catherine McCarty; James Riley
Other key lawyers
Theresa Kavanaugh; Scott Bluni; Duncan Greenhalgh; Michael Shuster